World Hepatitis D Epidemiology and Market Outlook to 2030, Featuring MYR Pharmaceuticals/Hepatera, Eiger Biopharmaceuticals and Janssen Biopharmaceuticals
10 mars 2021 04h18 HE
|
Research and Markets
Dublin, March 10, 2021 (GLOBE NEWSWIRE) -- The "Hepatitis D - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report...